feed,title,long_url,short_url
Benzinga,Novo Nordisk Stops Semaglutide Kidney Outcome Trial Based On Early Signs Of Efficacy,https://benzinga.com/general/biotech/23/10/35185290/novo-nordisk-stops-semaglutide-kidney-outcome-trial-based-on-early-signs-of-efficacy,https://da.gd/CwTV
